Phase I trial of RDEA 119 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Sep 2008
At a glance
- Drugs Refametinib (Primary)
- Indications Cancer; Inflammation
- Focus Adverse reactions
- Sponsors Ardea Biosciences
- 09 Sep 2008 Status changed from recruiting to completed.
- 18 Jun 2008 New trial record.